Rani Therapeutics Holdings Inc (NAS:RANI)
$ 1.42 0 (0%) Market Cap: 47.30 Mil Enterprise Value: 53.28 Mil PE Ratio: 0 PB Ratio: 13.52 GF Score: 30/100

Rani Therapeutics Holdings Inc at H.C. Wainwright BioConnect Investor Conference Transcript

May 02, 2023 / 03:30PM GMT
Release Date Price: $4.7 (-1.26%)
Mitchell Kapoor
H.C. Wainwright & Co., LLC - Analyst

Hi, everyone, and welcome to the H.C. Wainwright BioConnect conference. My name is Mitchell Kapoor; I'm a Senior Biotechnology Analyst here at H.C. Wainwright. I'm joined today by Talat Imran, the Chief Executive Officer of Rani Therapeutics. It's an exciting time for Rani, and I'm glad you could join us so that we could have a fireside chat. We're just going to have some Q&A back and forth. And hopefully, we'll touch on the main topics that are most important today. So thanks for joining us.

Talat Imran
Rani Therapeutics Holdings, Inc. - CEO

Thank you for having us, Mitchell, and thank you to H.C. Wainwright for making this possible. Really excited to be here.

Questions & Answers

Mitchell Kapoor
H.C. Wainwright & Co., LLC - Analyst

Absolutely. Maybe you could start off by giving us a brief introduction to Rani, where you are today. And then just an overview of the RaniPill in general, there's two generations. So if you could inform the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot